Published in Ophthalmology on August 12, 2010
Ocular Hypertension Treatment Study (OHTS) (OHTS) | NCT00000125
Assessing the effectiveness of intraocular pressure-lowering therapy. Ophthalmology (2010) 0.83
Comparing the efficacy of the monocular trial treatment paradigm with multiple measurements of intraocular pressure before and after treatment initiation in primary open-angle glaucoma. Clin Ophthalmol (2012) 0.75
Is the observed lowering of intraocular pressure due to treatment? Indian J Ophthalmol (2013) 0.75
Medical Management of Glaucoma in the 21st Century from a Canadian Perspective. J Ophthalmol (2016) 0.75
Changing face of glaucoma. Indian J Ophthalmol (2014) 0.75
Contralateral intraocular pressure lowering effect of prostaglandin analogues. Indian J Ophthalmol (2014) 0.75
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 16.89
The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol (1999) 3.30
The uniocular drug trial and second-eye response to glaucoma medications. Ophthalmology (2004) 3.10
Variation of 24-hour intraocular pressure in healthy individuals: right eye versus left eye. Ophthalmology (2005) 2.72
Diurnal variation of intraocular pressure in primary open-angle glaucoma. Am J Ophthalmol (1975) 1.98
A Prospective, randomized, investigator-masked evaluation of the monocular trial in ocular hypertension or open-angle glaucoma. Ophthalmology (2009) 1.76
Predicting response to glaucoma therapy in one eye based on response in the fellow eye: the monocular trial. Arch Ophthalmol (2008) 1.66
The one-eye trial and fellow eye response to prostaglandin analogues. Clin Experiment Ophthalmol (2008) 1.61
Individual variability in the diurnal intraocular pressure curve. Ophthalmology (1993) 1.27
Asymmetry of right versus left intraocular pressures over 24 hours in glaucoma patients. Ophthalmology (2006) 1.20
THE DIURNAL VARIATIONS OF OCULAR TENSION IN GLAUCOMA. Acta Ophthalmol Suppl (1964) 1.13
Variability of intraocular pressure measurements in observation participants in the ocular hypertension treatment study. Ophthalmology (2009) 1.06
Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study. Am J Ophthalmol (2000) 1.06
The dose response of human intraocular pressure to pilocarpine. Can J Ophthalmol (1971) 1.05
Diurnal fluctuation and concordance of intraocular pressure in glaucoma suspects and normal tension glaucoma patients. J Glaucoma (2007) 0.99
Concordance of diurnal intraocular pressure between fellow eyes in primary open-angle glaucoma. Ophthalmology (2007) 0.98
Frequency of asymmetric intraocular pressure fluctuations among patients with and without glaucoma. Ophthalmology (2002) 0.98
Discrepancy of the intraocular pressure response between fellow eyes in one-eye trials versus bilateral treatment: verification with normal subjects. J Glaucoma (2008) 0.97
Symmetry of fellow-eye intraocular pressure responses to topical glaucoma medications. Ophthalmology (2005) 0.93
The uniocular therapeutic trial in the management of elevated intraocular pressure. Surv Ophthalmol (1981) 0.90
Rationale for the one-eye therapeutic trial. Ann Ophthalmol (1986) 0.90
The One-Eye drug trial revisited. Ophthalmology (2004) 0.87
The management of elevated intraocular pressure with normal optic discs and visual fields. II. An approach to early therapy. Surv Ophthalmol (1977) 0.85
Interpretation of uniocular and binocular trials of glaucoma medications: an observational case series. BMC Ophthalmol (2007) 0.85
Studies of monocular trials of glaucoma medications: conflicting results explained by varying methods. Arch Ophthalmol (2009) 0.83
The monocular trial controversy: a critical review. Curr Opin Ophthalmol (2009) 0.82
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 16.89
The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 11.38
Evaluation of retinal nerve fiber layer, optic nerve head, and macular thickness measurements for glaucoma detection using optical coherence tomography. Am J Ophthalmol (2005) 4.83
A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol (2003) 4.35
Comparison of the GDx VCC scanning laser polarimeter, HRT II confocal scanning laser ophthalmoscope, and stratus OCT optical coherence tomograph for the detection of glaucoma. Arch Ophthalmol (2004) 4.01
Effect of improper scan alignment on retinal nerve fiber layer thickness measurements using Stratus optical coherence tomograph. J Glaucoma (2008) 3.18
Reproducibility of retinal nerve fiber thickness measurements using the stratus OCT in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci (2005) 3.02
Combining structural and functional testing for detection of glaucoma. Ophthalmology (2006) 2.97
Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a variability and diagnostic performance study. Ophthalmology (2009) 2.96
Sensitivity and specificity of the StratusOCT for perimetric glaucoma. Ophthalmology (2005) 2.91
Use of progressive glaucomatous optic disk change as the reference standard for evaluation of diagnostic tests in glaucoma. Am J Ophthalmol (2005) 2.84
Optic disc change with incipient myopia of childhood. Ophthalmology (2011) 2.77
Variation of 24-hour intraocular pressure in healthy individuals: right eye versus left eye. Ophthalmology (2005) 2.72
Continuous 24-hour monitoring of intraocular pressure patterns with a contact lens sensor: safety, tolerability, and reproducibility in patients with glaucoma. Arch Ophthalmol (2012) 2.70
Prevalence of ocular surface disease in glaucoma patients. J Glaucoma (2008) 2.65
The African Descent and Glaucoma Evaluation Study (ADAGES): design and baseline data. Arch Ophthalmol (2009) 2.59
Prediction of functional loss in glaucoma from progressive optic disc damage. Arch Ophthalmol (2009) 2.53
Macular ganglion cell-inner plexiform layer: automated detection and thickness reproducibility with spectral domain-optical coherence tomography in glaucoma. Invest Ophthalmol Vis Sci (2011) 2.46
Orbital cerebrospinal fluid space in glaucoma: the Beijing intracranial and intraocular pressure (iCOP) study. Ophthalmology (2012) 2.44
Comparison of retinal nerve fiber layer measurements using time domain and spectral domain optical coherent tomography. Ophthalmology (2009) 2.41
Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study. Am J Ophthalmol (2004) 2.39
Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci (2008) 2.37
Association between rates of binocular visual field loss and vision-related quality of life in patients with glaucoma. JAMA Ophthalmol (2013) 2.37
Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study. Ophthalmology (2012) 2.35
Reproducibility of RTVue retinal nerve fiber layer thickness and optic disc measurements and agreement with Stratus optical coherence tomography measurements. Am J Ophthalmol (2009) 2.33
Corneal hysteresis as a risk factor for glaucoma progression: a prospective longitudinal study. Ophthalmology (2013) 2.29
Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology (2006) 2.28
Cerebrospinal fluid exchange in the optic nerve in normal-tension glaucoma. Br J Ophthalmol (2011) 2.23
Five rules to evaluate the optic disc and retinal nerve fiber layer for glaucoma. Optometry (2005) 2.23
Structure-function relationships using confocal scanning laser ophthalmoscopy, optical coherence tomography, and scanning laser polarimetry. Invest Ophthalmol Vis Sci (2006) 2.17
Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol (2010) 2.14
Individualized compensation of anterior segment birefringence during scanning laser polarimetry. Invest Ophthalmol Vis Sci (2002) 2.13
Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma. Arch Ophthalmol (2005) 2.10
Tracking retinal microgliosis in models of retinal ganglion cell damage. Invest Ophthalmol Vis Sci (2012) 2.10
Differences in visual function and optic nerve structure between healthy eyes of blacks and whites. Arch Ophthalmol (2005) 2.09
Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss. Am J Ophthalmol (2004) 2.06
Glaucoma diagnostic accuracy of ganglion cell-inner plexiform layer thickness: comparison with nerve fiber layer and optic nerve head. Ophthalmology (2012) 2.04
The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch Ophthalmol (2004) 2.03
Quality of life in keratoconus. Am J Ophthalmol (2004) 2.03
SMARTPHONE-BASED DILATED FUNDUS PHOTOGRAPHY AND NEAR VISUAL ACUITY TESTING AS INEXPENSIVE SCREENING TOOLS TO DETECT REFERRAL WARRANTED DIABETIC EYE DISEASE. Retina (2016) 2.01
Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet (2012) 2.00
Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res (2003) 1.98
Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci (2003) 1.97
Detection of glaucoma progression with stratus OCT retinal nerve fiber layer, optic nerve head, and macular thickness measurements. Invest Ophthalmol Vis Sci (2009) 1.97
Effect of signal strength and improper alignment on the variability of stratus optical coherence tomography retinal nerve fiber layer thickness measurements. Am J Ophthalmol (2009) 1.96
African Descent and Glaucoma Evaluation Study (ADAGES): III. Ancestry differences in visual function in healthy eyes. Arch Ophthalmol (2010) 1.89
Retinal ganglion cell count estimates associated with early development of visual field defects in glaucoma. Ophthalmology (2012) 1.86
Evaluation of retinal nerve fiber layer progression in glaucoma: a study on optical coherence tomography guided progression analysis. Invest Ophthalmol Vis Sci (2009) 1.86
Influence of disease severity and optic disc size on the diagnostic performance of imaging instruments in glaucoma. Invest Ophthalmol Vis Sci (2006) 1.84
The structure and function relationship in glaucoma: implications for detection of progression and measurement of rates of change. Invest Ophthalmol Vis Sci (2012) 1.83
Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Arch Ophthalmol (2005) 1.80
Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study. Am J Ophthalmol (2006) 1.80
Detection of progressive retinal nerve fiber layer loss in glaucoma using scanning laser polarimetry with variable corneal compensation. Invest Ophthalmol Vis Sci (2008) 1.78
Reproducibility of peripapillary retinal nerve fiber layer thickness and optic nerve head parameters measured with cirrus HD-OCT in glaucomatous eyes. Invest Ophthalmol Vis Sci (2010) 1.77
Classification of visual field abnormalities in the ocular hypertension treatment study. Arch Ophthalmol (2003) 1.76
Recharacterization of the RGC-5 retinal ganglion cell line. Invest Ophthalmol Vis Sci (2009) 1.74
Aqueous humor dynamics in mice. Invest Ophthalmol Vis Sci (2003) 1.73
Diurnal intraocular pressure patterns are not repeatable in the short term in healthy individuals. Ophthalmology (2010) 1.72
Evaluation of the influence of corneal biomechanical properties on intraocular pressure measurements using the ocular response analyzer. J Glaucoma (2006) 1.72
Comparison of retinal nerve fiber layer and optic disc imaging for diagnosing glaucoma in patients suspected of having the disease. Ophthalmology (2008) 1.71
Primary open-angle glaucoma in blacks: a review. Surv Ophthalmol (2003) 1.70
Comparison of different spectral domain optical coherence tomography scanning areas for glaucoma diagnosis. Ophthalmology (2010) 1.68
Retinal nerve fiber layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss. Am J Ophthalmol (2004) 1.66
The Relationship between intraocular pressure and progressive retinal nerve fiber layer loss in glaucoma. Ophthalmology (2009) 1.65
Corneal thickness measurements and visual function abnormalities in ocular hypertensive patients. Am J Ophthalmol (2003) 1.64
Foveal hypoplasia demonstrated in vivo with optical coherence tomography. Am J Ophthalmol (2003) 1.64
Visualization of the lamina cribrosa using enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol (2011) 1.59
Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol (2003) 1.58
Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects. Am J Ophthalmol (2006) 1.58
Importance of vitreous liquefaction in age-related cataract. Invest Ophthalmol Vis Sci (2004) 1.56
Experimental mouse ocular hypertension: establishment of the model. Invest Ophthalmol Vis Sci (2003) 1.54
Combining structural and functional measurements to improve estimates of rates of glaucomatous progression. Am J Ophthalmol (2012) 1.54
Comparison of the diagnostic accuracies of the Spectralis, Cirrus, and RTVue optical coherence tomography devices in glaucoma. Ophthalmology (2011) 1.53
Structure and function evaluation (SAFE): II. Comparison of optic disk and visual field characteristics. Am J Ophthalmol (2003) 1.53
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev Drug Discov (2012) 1.52
An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Am J Ophthalmol (2004) 1.50
Rates of progressive retinal nerve fiber layer loss in glaucoma measured by scanning laser polarimetry. Am J Ophthalmol (2010) 1.49
Racial differences in optic disc topography: baseline results from the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study. Arch Ophthalmol (2004) 1.49
Structure and function evaluation (SAFE): I. criteria for glaucomatous visual field loss using standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP). Am J Ophthalmol (2002) 1.49
Mifepristone treatment of chronic central serous chorioretinopathy. Retina (2007) 1.48
Retinal nerve fiber layer thickness measured with optical coherence tomography is related to visual function in glaucomatous eyes. Ophthalmology (2003) 1.48
Comparing machine learning classifiers for diagnosing glaucoma from standard automated perimetry. Invest Ophthalmol Vis Sci (2002) 1.48
Performance of confocal scanning laser tomograph Topographic Change Analysis (TCA) for assessing glaucomatous progression. Invest Ophthalmol Vis Sci (2008) 1.47
Baseline visual field characteristics in the ocular hypertension treatment study. Ophthalmology (2002) 1.46
Combining structural and functional measurements to improve detection of glaucoma progression using Bayesian hierarchical models. Invest Ophthalmol Vis Sci (2011) 1.46